Skip to content

Ankle-foot Orthoses for Peripheral Artery Disease

Efficacy of Ankle-Foot Orthoses on Walking Ability in Peripheral Artery Disease: The AFO for PAD Trial I

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02280200
Enrollment
31
Registered
2014-10-31
Start date
2014-11-30
Completion date
2017-12-31
Last updated
2019-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease

Keywords

claudication, ankle foot orthoses, community walking exercise

Brief summary

The primary aim of this study is to investigate the effect of an ankle foot orthoses (AFO) on the primary outcome of peak walking time (PWT) in patients with peripheral artery disease (PAD).

Detailed description

The investigators will test the hypothesis that PAD patients using an AFO during a graded exercise test will demonstrate a greater PWT compared to PWT assessed without the use of an AFO. Secondary hypotheses include evaluation of the effect of an AFO on: 1) calf muscle function, 2) claudication onset time, 3) functional ability, 4) peak oxygen consumption, and 5) patient-reported outcomes. We will also examine the effects of the AFO on outcomes following 12 weeks of community walking.

Interventions

DEVICEAFO to improve outcomes

Ankle foot orthoses (AFO) are light-weight, low profile carbon fiber devices that store and release energy during ambulation. The AFO, in combination with standard of care advice to walk more, will be used to determine if there is any improvement in PAD patient outcomes.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women diagnosed with atherosclerotic peripheral arterial disease (PAD). * Patients who experience calf claudication * ≥40 years of age * An abnormal ankle-brachial index (ABI) of ≤.90. * For patients with an ABI \>.90 and \<1.00, a post-exercise ABI drop of 15% or more compared to the resting ABI

Exclusion criteria

* Lower extremity amputation(s) which interfere(s) with walking. * Critical limb ischemia (i.e., ischemic rest pain, ulcers/gangrene on the lower extremities). * Non-atherosclerotic PAD (e.g., popliteal entrapment syndrome, Takayasu's arteritis) * Major surgical procedures that are contraindicated to an exercise program (e.g., recent organ transplant) or coronary artery bypass graft within 6 months prior to screening. * Primarily limitations to exercise due to chronic obstructive pulmonary disease, angina or heart failure. * Myocardial infarction within 3 months prior to screening. * Acute coronary syndrome symptoms diagnosed at time of screening. * Significant ischemic changes (documented on the 12-lead electrocardiogram) with horizontal or down-sloping ST-segment depression ≥ 0.5mm at rest and \>1 mm with exercise in 3 beats for 2 contiguous leads, relative to the PR-segment (or ST-segment elevation ≥1mm). * Transient ischemic attack or stroke 3 months prior to screening. * New left bundle branch block or sustained ventricular tachycardia \>30 seconds during screening. * Uncontrolled hypertension defined as ≥180 systolic or ≥100 diastolic resting blood pressure during screening. * Women who are pregnant (women of childbearing potential, a pregnancy test will be performed at screening. * Individuals currently incarcerated. * Evidence of acute impairment from alcohol or other illicit drugs. * Lack of diabetes control (glycated hemoglobin \>12%) * Patients who are anemic (Hgb \<11 g/dL for women and \<10 g/dL for men). * Any other clinically significant diseases (e.g., pulmonary, renal, psychiatric, immunological) that are not stabilized or may otherwise confound the results of the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in WIQ Distance Subscore12 weeksIn the Walking Impairment Questionnaire distance subcategory, participants are asked to rate the degree of difficulty walking specific distances on a scale from 0 to 4. A score of 0 indicates the inability to walk the distance specified by the question while a score of 4 represents no difficulty. The graded sub-score is multiplied by a pre-specified weight for each sub-category: distance, speed, and number of flights of stairs. The products of these subscores are summed and divided by the maximum possible score to obtain a percent score, ranging from 0 (inability to perform item) to 100 (no difficulty in performing item).
Change in WIQ Speed Subscore12 weeksIn the Walking Impairment Questionnaire speed subcategory, participants are asked to rate the degree of difficulty walking one block at specific speeds, ranging from walking slowly to jogging, on a scale from 0 to 4. A score of 0 indicates the inability to walk the distance specified by the question while a score of 4 represents no difficulty. The graded sub-score is multiplied by a pre-specified weight for each sub-category: distance, speed, and number of flights of stairs. The products of these subscores are summed and divided by the maximum possible score to obtain a percent score, ranging from 0 (inability to perform item) to 100 (no difficulty in performing item).
Change in WIQ Stair-Climbing Subscore12 weeksIn the Walking Impairment Questionnaire stair-climbing subcategory, participants are asked to rate the degree of difficulty climbing a specified number of stair flights, ranging from 1 to 3 stair flights, on a graded scale of 0 to 4. A score of 0 indicates the inability to climb the flights specified by the question while a score of 4 represents no difficulty. The graded sub-score is multiplied by a pre-specified weight for each sub-category: distance, speed, and number of flights of stairs. The products of these subscores are summed and divided by the maximum possible score to obtain a percent score, ranging from 0 (inability to perform item) to 100 (no difficulty in performing item).
Change in SF-36 PCS12 weeksChange in Medical Outcomes Study Short Form 36-item questionnaire, Physical Component Summary The SF-36 has eight scaled subscores (Vitality, Physical functioning, Bodily pain, General health perceptions, Physical role functioning, Emotional role functioning, Social role functioning, Mental health). These subscores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability.
Change in SF-36 MCS12 weeksChange in Medical Outcomes Study Short Form 36-item questionnaire, Mental Component Summary The SF-36 has eight scaled subscores (Vitality, Physical functioning, Bodily pain, General health perceptions, Physical role functioning, Emotional role functioning, Social role functioning, Mental health). These subscores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability.

Countries

United States

Participant flow

Participants by arm

ArmCount
AFO to Improve Outcomes
open label, non-interventional design (all patients who volunteer for trial receive AFO) AFO to improve outcomes: Ankle foot orthoses (AFO) are light-weight, low profile carbon fiber devices that store and release energy during ambulation. The AFO, in combination with standard of care advice to walk more, will be used to determine if there is any improvement in PAD patient outcomes.
15
Historical Controls
Historical PAD control group (n = 10) received upfront advice to walk at home with no intervention
10
Total25

Baseline characteristics

CharacteristicHistorical ControlsTotalAFO to Improve Outcomes
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants12 Participants9 Participants
Age, Categorical
Between 18 and 65 years
7 Participants13 Participants6 Participants
Age, Continuous63.1 years
STANDARD_DEVIATION 6.7
65.7 years
STANDARD_DEVIATION 10.5
67.4 years
STANDARD_DEVIATION 12.4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
5 Participants5 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants19 Participants14 Participants
Region of Enrollment
United States
10 participants25 participants15 participants
Sex: Female, Male
Female
2 Participants8 Participants6 Participants
Sex: Female, Male
Male
8 Participants17 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 10
other
Total, other adverse events
0 / 150 / 10
serious
Total, serious adverse events
3 / 150 / 10

Outcome results

Primary

Change in SF-36 MCS

Change in Medical Outcomes Study Short Form 36-item questionnaire, Mental Component Summary The SF-36 has eight scaled subscores (Vitality, Physical functioning, Bodily pain, General health perceptions, Physical role functioning, Emotional role functioning, Social role functioning, Mental health). These subscores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
AFO to Improve OutcomesChange in SF-36 MCS4.3 Scale unitsStandard Deviation 7.6
Historical ControlsChange in SF-36 MCS-1.1 Scale unitsStandard Deviation 6
Primary

Change in SF-36 PCS

Change in Medical Outcomes Study Short Form 36-item questionnaire, Physical Component Summary The SF-36 has eight scaled subscores (Vitality, Physical functioning, Bodily pain, General health perceptions, Physical role functioning, Emotional role functioning, Social role functioning, Mental health). These subscores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
AFO to Improve OutcomesChange in SF-36 PCS2.9 Scale unitsStandard Deviation 5
Historical ControlsChange in SF-36 PCS2.1 Scale unitsStandard Deviation 6.7
Primary

Change in WIQ Distance Subscore

In the Walking Impairment Questionnaire distance subcategory, participants are asked to rate the degree of difficulty walking specific distances on a scale from 0 to 4. A score of 0 indicates the inability to walk the distance specified by the question while a score of 4 represents no difficulty. The graded sub-score is multiplied by a pre-specified weight for each sub-category: distance, speed, and number of flights of stairs. The products of these subscores are summed and divided by the maximum possible score to obtain a percent score, ranging from 0 (inability to perform item) to 100 (no difficulty in performing item).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
AFO to Improve OutcomesChange in WIQ Distance Subscore22.7 Scale unitsStandard Deviation 24.5
Historical ControlsChange in WIQ Distance Subscore-7.2 Scale unitsStandard Deviation 13.2
Primary

Change in WIQ Speed Subscore

In the Walking Impairment Questionnaire speed subcategory, participants are asked to rate the degree of difficulty walking one block at specific speeds, ranging from walking slowly to jogging, on a scale from 0 to 4. A score of 0 indicates the inability to walk the distance specified by the question while a score of 4 represents no difficulty. The graded sub-score is multiplied by a pre-specified weight for each sub-category: distance, speed, and number of flights of stairs. The products of these subscores are summed and divided by the maximum possible score to obtain a percent score, ranging from 0 (inability to perform item) to 100 (no difficulty in performing item).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
AFO to Improve OutcomesChange in WIQ Speed Subscore14.9 Scale unitsStandard Deviation 17.1
Historical ControlsChange in WIQ Speed Subscore-7.5 Scale unitsStandard Deviation 19.6
Primary

Change in WIQ Stair-Climbing Subscore

In the Walking Impairment Questionnaire stair-climbing subcategory, participants are asked to rate the degree of difficulty climbing a specified number of stair flights, ranging from 1 to 3 stair flights, on a graded scale of 0 to 4. A score of 0 indicates the inability to climb the flights specified by the question while a score of 4 represents no difficulty. The graded sub-score is multiplied by a pre-specified weight for each sub-category: distance, speed, and number of flights of stairs. The products of these subscores are summed and divided by the maximum possible score to obtain a percent score, ranging from 0 (inability to perform item) to 100 (no difficulty in performing item).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
AFO to Improve OutcomesChange in WIQ Stair-Climbing Subscore18.9 percent of scoreStandard Deviation 23.5
Historical ControlsChange in WIQ Stair-Climbing Subscore0 percent of scoreStandard Deviation 37.2

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026